ANDREW TIMPSON
@Silverarc Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters
Portfolio positions
This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
4576⤦Insmed Inc
| 0% | $16.75M↑ Call 250,000 shares@ $67.0 avg price | Exited |
MORFMorphic Hldg Inc
| 0% | $16.568M 486,306 shares@ $34.07 avg price | Exited |
MIRMMirum Pharmaceuticals Inc
| 0% | $2.708M 79,194 shares@ $34.2 avg price | Exited |
JSPRJasper Therapeutics Inc
| 0% | $2.495M 109,892 shares@ $22.7 avg price | Exited |
ENGNEngene Holdings Inc
| 0% | $2.488M 263,841 shares@ $9.44 avg price | Exited |
FULCFulcrum Therapeutics Inc
| 0% | $2.47M 398,436 shares@ $6.2 avg price | Exited |
EVGNEvogene Ltd
| 0% | $2.003M 3.08M shares@ $0.66 avg price | Exited |
STOKStoke Therapeutics Inc
| 0% | $1.912M 141,518 shares@ $13.51 avg price | Exited |
MGNXMacrogenics Inc
| 0% | $1.573M 370,000 shares@ $4.25 avg price | Exited |
ZURAZura Bio Ltd
| 0% | $1.15M 328,504 shares@ $3.5 avg price | Exited |